2018 대한부정맥학회 비판막성 심방세동 환자의 뇌졸중 예방 지침

2018 KHRS Guidelines for Stroke Prevention Therapy in Korean Patients with Nonvalvular Atrial Fibrillation

Article information

Korean J Med. 2018;93(3):311-312

Publication date (electronic) : 2018 June 1

doi : https://doi.org/10.3904/kjm.2018.93.2.87.e1

Jung Myung Lee ¹, Boyoung Joung ², Myung-Jin Cha ³, Ji Hyun Lee ⁴, Woo Hyun Lim ⁵, Tae-Hoon Kim ², Seung Yong Shin ⁶, Jae-Sun Uhm ², Hong Euy Lim ⁷, Jin-Bae Kim ¹, Jun Soo Kim ⁸

¹Division of Cardiology, Kyung Hee University Hospital, Seoul, Korea

²Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea

³Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea

⁴Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea

⁵Division of Cardiology, Department of Internal Medicine, Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea

⁶Department of Cardiology, Chung-Ang University Hospital, Seoul, Korea

⁷Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea

⁸Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

이정명¹, 정보영², 차명진³, 이지현⁴, 임우현⁵, 김태훈², 신승용⁶, 엄재선², 임홍의⁷, 김진배¹, 김준수⁸

¹경희대학교병원 순환기내과

²연세대학교 세브란스병원 순환기내과

³서울대학교병원 순환기내과

⁴서울대학교 분당병원 순환기내과

⁵서울대학교 보라매병원 순환기내과

⁶중앙대학교병원 순환기내과

⁷고려대학교 구로병원 순환기내과

⁸성균관대학교 삼성서울병원 순환기내과

Korean J Med 2018;93:87-109. https://doi.org/10.3904/kjm.2018.93.2.87

다음과 같이 본문 내 Table 5에 오류가 있어 수정합니다.

Table 5.

Guidance for temporary interruption of NOAC before surgery

Table 5.

Guidance for temporary interruption of NOAC before surgery

Article information Continued

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Table 5.

Guidance for temporary interruption of NOAC before surgery

	Dabigatran	Apixaban, edoxaban, rivaroxaban	Low-risk surgery	High-risk surgery
	Low-risk surgery	High-risk surgery	Low-risk surgery	High-risk surgery
Creatinine clearance >80 mL/min	24 hours	48 hours	24 hours	48 hours
Creatinine clearance 50-80 mL/min	36 hours	72 hours	24 hours	48 hours
Creatinine clearance 30-50 mL/min	48 hours	96 hours	24 hours	48 hours
Creatinine clearance 15-30 mL/min	Not indicated	Not indicated	36 hours	48 hours

NOAC, non-vitamin K antagonist oral anticoagulant.

Table 5.

Guidance for temporary interruption of NOAC before surgery

	Dabigatran		Apixaban, edoxaban, rivaroxaban
	Low risk surgery	High risk surgery	Low risk surgery	High risk surgery
Creatinine clearance >80 mL/min	24 hours	48 hours	24 hours	48 hours
Creatinine clearance 50-80 mL/min	36 hours	72 hours	24 hours	48 hours
Creatinine clearance 30-50 mL/min	48 hours	96 hours	24 hours	48 hours
Creatinine clearance 15-30 mL/min	Not indicated	Not indicated	36 hours	48 hours

NOAC, non-vitamin K antagonist oral anticoagulant.